Literature DB >> 7595400

Disruption of PML-associated nuclear bodies during human cytomegalovirus infection.

C Kelly1, R Van Driel, G W Wilkinson.   

Abstract

PML is a protein associated with discrete spherical structures within the nucleus of normal cells. A defect in PML expression is observed in acute promyelocytic leukaemia as a consequence of a chromosomal translocation involving the genes encoding PML and the alpha retinoic acid receptor (RAR alpha). Disruption of PML bodies also occurs during herpes simplex virus infection after the immediate early protein Vmw110 has become associated with PML bodies. In this study, we followed the fate of PML bodies in human fibroblasts during the course of a human cytomegalovirus (CMV) infection. Disruption of PML bodies was observed to be dependent on de novo CMV gene expression and to occur within 4 h post-infection, concomitant with the onset of CMV IE gene expression. Although a transient increase in the number of PML bodies could be observed in some cells, PML exists predominantly as a diffuse nuclear protein during both the early and late stages of CMV infection. Although the function of PML bodies is still uncertain, their disruption may be important for efficient herpes virus replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595400     DOI: 10.1099/0022-1317-76-11-2887

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  42 in total

1.  Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication.

Authors:  F D Goodrum; D A Ornelles
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.

Authors:  S Müller; A Dejean
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 3.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.

Authors:  Michael Nevels; Wolfram Brune; Thomas Shenk
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies.

Authors:  Yi-Jia Li; Thomas Macnaughton; Lu Gao; Michael M C Lai
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression.

Authors:  Young-Eui Kim; Jin-Hyoung Lee; Eui Tae Kim; Hye Jin Shin; Su Yeon Gu; Hyang Sook Seol; Paul D Ling; Chan Hee Lee; Jin-Hyun Ahn
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

8.  Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7.

Authors:  Sama Tamrakar; Anokhi J Kapasi; Deborah H Spector
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

9.  The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments.

Authors:  Pei Xu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 10.  Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape.

Authors:  Santo Landolfo; Marco De Andrea; Valentina Dell'Oste; Francesca Gugliesi
Journal:  World J Virol       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.